European green light for Allergan’s Ozurdex
May 25, 2010Sales and Marketing Allergan, CHMP, Ozurdex, macular oedema
European authorities have given the green light for Ozurdex, a treatment for adults with a potentially serious eye disease. Ozurdex …
Takeda appoints Kiyohiko Tamura
May 25, 2010Sales and Marketing Takeda, appointment, sales and marketing
Japanese pharma company Takeda has appointed Kiyohiko Tamura general manager of its newly established Office of the President & CEO. …
MMR doctor struck off
May 25, 2010GMC, MMR
The doctor at the centre of a 12-year MMR vaccine debate has been struck off the medical register after being …
Kaiser Permanente unit joins Quintiles ‘Prime Site’ network
May 25, 2010Research and Development CRO, Kaiser Permanente, Quintiles
A unit of US health maintenance organisation Kaiser Permanente has become the fourth in Quintiles’ network of ‘Prime Sites’ – …
Lucentis boosted by diabetic vision study
May 24, 2010Research and Development, Sales and Marketing AMD, DME, Lucentis, Novartis
A phase III trial of Novartis’ ranibizumab has shown it to be superior at promoting vision gain in patients with …
Boehringer selects lead candidate for Alzheimer’s
May 24, 2010Research and Development Ablynx, Boehringer
Boehringer Ingelheim has selected a lead candidate for further development to treat Alzheimer’s disease from its collaboration with Ablynx. Belgium-based …
Eisai opens $100m parenterals plant in North Carolina
May 24, 2010Manufacturing and Production, Research and Development Aricept, Eisai, eribulin, parenterals
Japanese drugmaker Eisai has opened a 65,000-sq.ft. facility at Research Triangle Park in North Carolina, USA, which will serve as …
First artificial life created
May 24, 2010Research and Development Cell biology, Venter, cell, genome
Scientists in the US have succeeded in developing the first living cell to be controlled entirely by synthetic DNA. The …
Pharma manufacturing news in brief
May 24, 2010Manufacturing and Production Angel Biotech, Halozyme, Johnson Matthey, Ranbaxy, Sagent Pharmaceuticals, baxter
There are more quality problems to report on the manufacturing beat this week, with recalls for Ranbaxy, Halozyme/Baxter and Sagent …
Asda cuts cancer drugs prices
May 24, 2010Sales and Marketing Asda, Cancer, market access, price cuts, pricing, supermarket
UK supermarket chain Asda has started selling privately prescribed cancer drugs on a not-for-profit basis. The vast majority of drugs …
Turkey: volatility and growth
May 24, 2010Sales and Marketing Turkey, em
The economic woes of Greece are currently the most worrying problem within the European Union’s single currency region the Eurozone, …
German patent setback for GlaxoSmithKline’s Seretide
May 21, 2010Sales and Marketing GSK, Germany, Seretide
A Munich court has ruled GlaxoSmithKline’s combination patent for its asthma and COPD treatment Seretide is not valid. The Federal …
Digital Pharma: Doctors.net.uk’s Nordic expansion
May 21, 2010Medical Communications, Sales and Marketing community, digital pharma, doctors.net, meduniverse
UK online doctors network Doctors.net.uk has taken a stake in its Swedish counterpart MedUniverse as part of international expansion plans. …
Abbott poised to take top spot in India
May 21, 2010Sales and Marketing Abbott, India, Piramal, em
Abbott has acquired Indian firm Piramal’s Healthcare Solutions business in a deal that is set to make it the number …
Woolley Pau wins Galderma UK account
May 21, 2010Medical Communications Galderma, Woolley Pau
Dermatology specialist Galderma UK has appointed advertising agency Woolley Pau to work on a number of product launches. The agency …
UK government sets out its vision for health
May 21, 2010NHS, election, government
The NHS can expect real term increases in health spending and a significant reduction in its administration burden, according to …
Silence Therapeutics promotes Jorg Kaufmann
May 21, 2010Research and Development Silence Therapeutics, appointment, research and development, rnai
Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …
Digital Pharma: Boehringer readies ‘diabetes hub’
May 20, 2010Medical Communications Boehringer, digital pharma, disease awareness campaigns, patient information
Boehringer Ingelheim will shortly unveil a ‘digital diabetes hub’ that combines educational videos, research tools, educational games and information on …
Sanofi under investigation for anti-competitive practices
May 20, 2010Sales and Marketing Plavix, Sanofi
Sanofi-Aventis is to be investigated by the French Competition Authority for anti-competitive practices, following allegations it prevented the launch of …
Roche discontinues arthritis drug trials
May 20, 2010Sales and Marketing RA, Roche
Roche and Biogen Idec will discontinue clinical trials for rheumatoid arthritis drug ocrelizumab. Development of the RA treatment was halted …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
